170 related articles for article (PubMed ID: 20567954)
1. p21-activated kinase 5 inhibits camptothecin-induced apoptosis in colorectal carcinoma cells.
Wang X; Gong W; Qing H; Geng Y; Wang X; Zhang Y; Peng L; Zhang H; Jiang B
Tumour Biol; 2010 Dec; 31(6):575-82. PubMed ID: 20567954
[TBL] [Abstract][Full Text] [Related]
2. P21-activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration.
Gong W; An Z; Wang Y; Pan X; Fang W; Jiang B; Zhang H
Int J Cancer; 2009 Aug; 125(3):548-55. PubMed ID: 19415746
[TBL] [Abstract][Full Text] [Related]
3. p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD.
Cotteret S; Jaffer ZM; Beeser A; Chernoff J
Mol Cell Biol; 2003 Aug; 23(16):5526-39. PubMed ID: 12897128
[TBL] [Abstract][Full Text] [Related]
4. PAK5 facilitates the proliferation, invasion and migration in colorectal cancer cells.
Huang S; Zhu Y; Wang C; Li X; Cui X; Tu S; You L; Fu J; Chen Z; Hu W; Gong W
Cancer Med; 2020 Jul; 9(13):4777-4790. PubMed ID: 32383357
[TBL] [Abstract][Full Text] [Related]
5. PAK5-Egr1-MMP2 signaling controls the migration and invasion in breast cancer cell.
Wang XX; Cheng Q; Zhang SN; Qian HY; Wu JX; Tian H; Pei DS; Zheng JN
Tumour Biol; 2013 Oct; 34(5):2721-9. PubMed ID: 23696025
[TBL] [Abstract][Full Text] [Related]
6. PAK5 Induces EMT and Promotes Cell Migration and Invasion by Activating the PI3K/AKT Pathway in Ovarian Cancer.
Li D; Pan Y; Huang Y; Zhang P; Fang X
Anal Cell Pathol (Amst); 2018; 2018():8073124. PubMed ID: 30245957
[TBL] [Abstract][Full Text] [Related]
7. p21-Activated kinase 5 affects cisplatin-induced apoptosis and proliferation in hepatocellular carcinoma cells.
Zhang DG; Zhang J; Mao LL; Wu JX; Cao WJ; Zheng JN; Pei DS
Tumour Biol; 2015 May; 36(5):3685-91. PubMed ID: 25560489
[TBL] [Abstract][Full Text] [Related]
8. Nucleocytoplasmic shuttling of Pak5 regulates its antiapoptotic properties.
Cotteret S; Chernoff J
Mol Cell Biol; 2006 Apr; 26(8):3215-30. PubMed ID: 16581795
[TBL] [Abstract][Full Text] [Related]
9. Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain.
Pandey A; Dan I; Kristiansen TZ; Watanabe NM; Voldby J; Kajikawa E; Khosravi-Far R; Blagoev B; Mann M
Oncogene; 2002 May; 21(24):3939-48. PubMed ID: 12032833
[TBL] [Abstract][Full Text] [Related]
10. p21-Activated kinase 5: a pleiotropic kinase.
Wen YY; Wang XX; Pei DS; Zheng JN
Bioorg Med Chem Lett; 2013 Dec; 23(24):6636-9. PubMed ID: 24215894
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway.
Han ZX; Wang XX; Zhang SN; Wu JX; Qian HY; Wen YY; Tian H; Pei DS; Zheng JN
Brain Tumor Pathol; 2014 Oct; 31(4):234-41. PubMed ID: 24062079
[TBL] [Abstract][Full Text] [Related]
12. PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo.
Zhang YC; Huo FC; Wei LL; Gong CC; Pan YJ; Mou J; Pei DS
J Exp Clin Cancer Res; 2017 Oct; 36(1):146. PubMed ID: 29041983
[TBL] [Abstract][Full Text] [Related]
13. PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.
Zhu G; Li X; Guo B; Ke Q; Dong M; Li F
Oncogene; 2016 Apr; 35(15):1943-54. PubMed ID: 26212009
[TBL] [Abstract][Full Text] [Related]
14. PAK5-mediated AIF phosphorylation inhibits its nuclear translocation and promotes breast cancer tumorigenesis.
Xing Y; Li Y; Hu B; Han F; Zhao X; Zhang H; Li Y; Li D; Li J; Jin F; Li F
Int J Biol Sci; 2021; 17(5):1315-1327. PubMed ID: 33867848
[TBL] [Abstract][Full Text] [Related]
15. An oncogenic kinase: putting PAK5 forward.
Wen YY; Zheng JN; Pei DS
Expert Opin Ther Targets; 2014 Jul; 18(7):807-15. PubMed ID: 24869804
[TBL] [Abstract][Full Text] [Related]
16. Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells.
Schulze-Bergkamen H; Ehrenberg R; Hickmann L; Vick B; Urbanik T; Schimanski CC; Berger MR; Schad A; Weber A; Heeger S; Galle PR; Moehler M
World J Gastroenterol; 2008 Jun; 14(24):3829-40. PubMed ID: 18609706
[TBL] [Abstract][Full Text] [Related]
17. The overexpression of P21-activated kinase 5 (PAK5) promotes paclitaxel-chemoresistance of epithelial ovarian cancer.
Li D; Yao X; Zhang P
Mol Cell Biochem; 2013 Nov; 383(1-2):191-9. PubMed ID: 23877225
[TBL] [Abstract][Full Text] [Related]
18. CSRP2 suppresses colorectal cancer progression
Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
[TBL] [Abstract][Full Text] [Related]
19. p120-catenin is a binding partner and substrate for Group B Pak kinases.
Wong LE; Reynolds AB; Dissanayaka NT; Minden A
J Cell Biochem; 2010 Aug; 110(5):1244-54. PubMed ID: 20564219
[TBL] [Abstract][Full Text] [Related]
20. miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma.
Zhai J; Qu S; Li X; Zhong J; Chen X; Qu Z; Wu D
Biochem Biophys Res Commun; 2015 Aug; 464(1):161-7. PubMed ID: 26116538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
